MedTrace Logo

The Use of Air Cleaners to Mitigate Cardiopulmonary Health Impact of Indoor Exposure to Particles and Phthalates

NCT03500614 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 57

Last updated 2021-10-15

No results posted yet for this study

Summary

This study aims to evaluate whether a short-term intervention strategy using air cleaner reduces indoor exposure to airborne particles (particulate matter with an aerodynamic diameter ≤2.5μm, PM2.5) and phthalates and improves cardiopulmonary health among Chinese healthy adults based on a randomized double-blinded crossover trial.

Conditions

  • Blood Pressure
  • Lung Function
  • Inflammation
  • Oxidative Stress

Interventions

BEHAVIORAL

Air cleaner use method 1

All interventions in the first cohort will start at noon on Tuesday or Thursday and continue to the next morning of Tuesday or Thursday.

BEHAVIORAL

Air cleaner use method 2

All interventions in the second cohort will start from the beginning to the end of smog episodes.

Sponsors & Collaborators

  • Peking University

    lead OTHER

Principal Investigators

  • Jing Huang, PhD · Peking University

  • Shaowei Wu, PhD · Peking University

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
30 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-11-14
Primary Completion
2018-04-23
Completion
2018-12-01

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03500614 on ClinicalTrials.gov